BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21586608)

  • 1. Diffusion tensor imaging of prostate at 3.0 Tesla.
    Li C; Chen M; Li S; Zhao X; Zhang C; Liu M; Zhou C
    Acta Radiol; 2011 Sep; 52(7):813-7. PubMed ID: 21586608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
    Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
    Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
    Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
    Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion tensor magnetic resonance imaging of prostate cancer.
    Manenti G; Carlani M; Mancino S; Colangelo V; Di Roma M; Squillaci E; Simonetti G
    Invest Radiol; 2007 Jun; 42(6):412-9. PubMed ID: 17507813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer.
    Rosenkrantz AB; Sigmund EE; Johnson G; Babb JS; Mussi TC; Melamed J; Taneja SS; Lee VS; Jensen JH
    Radiology; 2012 Jul; 264(1):126-35. PubMed ID: 22550312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADC value and diffusion tensor imaging of prostate cancer: changes in carbon-ion radiotherapy.
    Takayama Y; Kishimoto R; Hanaoka S; Nonaka H; Kandatsu S; Tsuji H; Tsujii H; Ikehira H; Obata T
    J Magn Reson Imaging; 2008 Jun; 27(6):1331-5. PubMed ID: 18504751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion tensor magnetic resonance imaging of the normal breast.
    Partridge SC; Murthy RS; Ziadloo A; White SW; Allison KH; Lehman CD
    Magn Reson Imaging; 2010 Apr; 28(3):320-8. PubMed ID: 20061111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-tensor MRI at 3 T: differentiation of central gland prostate cancer from benign prostatic hyperplasia.
    Park SY; Kim CK; Park BK; Ha SY; Kwon GY; Kim B
    AJR Am J Roentgenol; 2014 Mar; 202(3):W254-62. PubMed ID: 24555622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of DTI in prostate cancer.
    Gürses B; Tasdelen N; Yencilek F; Kılıckesmez NO; Alp T; Fırat Z; Albayrak MS; Uluğ AM; Gürmen AN
    Eur J Radiol; 2011 Aug; 79(2):172-6. PubMed ID: 20138721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary study of astrocytic tumors by diffusion tensor imaging].
    Zhang WD; Liang BL; Huang SQ; Ye RX
    Ai Zheng; 2004 Mar; 23(3):317-21. PubMed ID: 15025966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging.
    Wu LM; Zhou B; Lu Q; Suo ST; Liu Q; Hu J; Haccke EM; Chen XX; Xu JR
    Clin Radiol; 2016 Apr; 71(4):356-62. PubMed ID: 26823021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the diagnostic performances of diffusion parameters in diffusion weighted imaging and diffusion tensor imaging of breast lesions.
    Cakir O; Arslan A; Inan N; Anık Y; Sarısoy T; Gumustas S; Akansel G
    Eur J Radiol; 2013 Dec; 82(12):e801-6. PubMed ID: 24099642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion tensor imaging (DTI) of the kidney at 3 tesla-feasibility, protocol evaluation and comparison to 1.5 Tesla.
    Notohamiprodjo M; Dietrich O; Horger W; Horng A; Helck AD; Herrmann KA; Reiser MF; Glaser C
    Invest Radiol; 2010 May; 45(5):245-54. PubMed ID: 20375845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging.
    Issa B
    J Magn Reson Imaging; 2002 Aug; 16(2):196-200. PubMed ID: 12203768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
    Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM
    AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor imaging assessment of brain white matter maturation during the first postnatal year.
    Provenzale JM; Liang L; DeLong D; White LE
    AJR Am J Roentgenol; 2007 Aug; 189(2):476-86. PubMed ID: 17646476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of diffusion tensor imaging in assessing superficial myometrial invasion by endometrial carcinoma: a preliminary study.
    Zhang L; Liu A; Zhang T; Song Q; Wei Q; Wang H
    Acta Radiol; 2015 Oct; 56(10):1273-80. PubMed ID: 25332442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of diffusion-weighted MRI for prostate cancer detection and localization.
    Yağci AB; Ozari N; Aybek Z; Düzcan E
    Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.
    Haider MA; van der Kwast TH; Tanguay J; Evans AJ; Hashmi AT; Lockwood G; Trachtenberg J
    AJR Am J Roentgenol; 2007 Aug; 189(2):323-8. PubMed ID: 17646457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.